603717.CG▼
Tianyu Bio's 2026 interim net loss of 54.3763 million yuan, swinging from profit to loss
Tianyu Bio released its 2026 interim report. Total operating revenue was 351 million yuan, down 14.95% year on year. Net profit attributable to the parent company was negative 54.3763 million yuan, a decrease of 65.1943 million yuan from the same period last year, a decline of 602.65%, swinging from profit to loss. Net cash flow from operating activities was negative 5.2863 million yuan, down 105.89% year on year. The company's asset-liability ratio rose to 80.99%, gross margin was negative 0.97%, return on equity was negative 16.05%, and diluted earnings per share was negative 0.19 yuan.